Detection of preclinical left ventricular dysfunction in Fabry disease: The contribution of tissue Doppler;Detecção de disfunção ventricular esquerda pré-clínica na doença de Fabry - Qual o contributo do Doppler tecidular?

Revista Portuguesa de Cardiologia

Volumn 25, Issue 6, 2006, Pages 613-637

  Fiuza, Manuela ^a   Avó, Luís Brito ^a   Oliveira, Eduardo I ^a   Gonçalves, Susana ^a   Lopes, Mário G ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Fabry disease; Left ventricular function; Strain and strain rate; Tissue Doppler

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; FABRY DISEASE; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; INTERMETHOD COMPARISON; MALE; SYSTOLE; TISSUE DOPPLER; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED;

ADULT; FABRY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34249066809     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Brady RO, Gal AE, Bradley RM, et al. Enzymatic defect in Fabry s disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967;276:1163-7.
2. MacDermot KD, Holmes A, Miners AH. Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis 2001;24 (Suppl 2):13-4.
3. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001;38:769-75.
4. Nagueh SF. Fabry disease. Heart 2003;89:819-20.
5. Linhart A, Palecek T, Bultas J, et al. New insights in cardiac structural changes in patients with Fabry s disease. Am Heart J 2000;139:1101-8.
6. Linhar t A, Lubanda JC, Palecek T, et al . Cardiac manifestations in Fabry disease. J Inherit Metab Dis 2001;24 (Suppl II):75-83.
7. Metha J, Tuna N, Mol ler JH, Desnick RJ. Electrocardiographic and vectocardiographic abnormalities in Fabry s disease. Am Heart J 1977;93:699-705.
8. Sachdev B, Takenaka T, Teraguchi H, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002;105:1407-11.
9. Goldman ME, Cantor R, Schwartz MF, et al. Echocardiographic abnormalities and disease severity in Fabry s disease. J Am Coll Cardiol 1986;7:1157-61.
10. Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry s disease. N Engl J Med 2001;345:9-16.
11. Schiffmann R, Kopp JB, Austin HA III, et al. Enzyme replacement therapy in Fabry s disease: a randomized controlled trial. JAMA 2001;285:2743-9.
12. Nagueh SF, Bachinski LL, Meyer D, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-30.
13. Pieroni M, Chimenti C, Ricci R, et al. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 2003;107:1978-84.
14. D hooge J, Heimdal A, Jamal F, et al. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiography 2000;1:154-70.
15. American Society of Echocardiography Committee on Standards, Recommendations for quantification of left ventricle by two-dimensional echocardiography. J Am Soc Echocardiog 1989;2:358-67.
16. Devereaux RB, Alonso D, Lutas E, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
17. Folland ED, Parisi AF, Moynihan PF, et al. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. Circulation 1979;60: 760-6.
18. Oh JK, Appleton CP, Hattle LK et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiog 1997;10:246-70.
19. Takatsuji H, Mikami T, Urasawa K et al. A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography. J Am Coll Cardiol 1996;27:365-71.
20. Gulati VK, Katz WE, Follansbee WP, et al. Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol 1996; 77:979-84.
21. Pan C, Hoffman R, Kuhl H et al. Tissue tracking allows rapid and accurate visual evaluation of left ventricular function. Eur J Echocardiography 2001;2:197-202.
22. Brodin L. Tissue Doppler, a fundamental tool for paramet ric imaging. Cl in Physiol Funct Imaging 2004;24:147-55.
23. Yip G, Abraham T, Belohlavek M et al. Cl inical applications of strain rate imaging. J Am Soc Echocardiog 2003;16: 1334-42.
24. Omnen SR. Echocardiographic assessment of diastolic function. Curr Opin Cardiol 2001;16:240-5.
25. Moller JE, Sondergaard E, Poulsen SH, et al. Color Mmode and pulsed wave tissue Doppler echocardiography: powerful predictors of cardiac events after first myocardial infarction. J Am Soc Echocardiogr 2001;14:575-63.
26. Zehetgruber MG. Tissue Doppler imaging: myocardial velocities and strain - are there clinical applications? J Clin Basic Cardiol 2002;5:125-32.
27. Gulati VK, Katz WE, Follansbee WP, et al. Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol 1996; 77:979-84.
28. Chimenti C, Pieroni M, Morgante E, et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 2004;110:1047-53.
29. Andersen NH, Poulsen SH. Evaluat ion of the longitudinal contraction of the left ventricle in normal subjects by Doppler tissue tracking and strain rate. J Am Soc Echocardiogr 2003;16:716-23.
30. Pislaru C, Abraham TP, Belohlavek M. Strain and strain rate echocardiography. Curr Opinion Cardiol 2002;17:443-54.
31. Trambaiolo P, Tonti G, Salustri A, et al. New insights into regional systolic and diastolic left ventricular function with tissue Doppler echocardiography: from qualitative analysis to a quantitative approach. J Am Soc Echocardiogr 2001;14:85-96.
32. Kukulski T, Jamal F, Herbots L, et al. Identification of acutely ischemic myocardium using ultrasonic strain measurements: a clinical study in patients undergoing coronary angioplasty. J Am Coll Cardiol 2003;41:810-19.
33. Edvarsen T, Skulstad H, Aakhus S, et al. Regional myocardial systolic function dur ing acute myocardial ischemia assessed by strain Doppler echocardiography. J Am Coll Cardiol 2001;37:726-30.
34. Tomoko SK, Noda A, Isawa H, et al. Discrimination of nonobstruct ive hyper trophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 2004;110: 3808-14.
35. Fang ZY, Yuda S, Anderson V, et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003;41:611-17.
36. Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulat ion 2003;107:2446-52.
37. Poulsen SH, Andersen NH, Ivarsen PI, et al. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent isolated diastolic dysfunction. J Am Soc Echocardiogr 2003;16:724-31.
38. Weidemann F, Breunig F, Beer M, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease. A prospective strain rate imaging study. Circulation 2003;108:1299-1301.
39. Castela S, Azarine A, Mousseaux E. Doença de Fabry - Avaliação pela Ressonância Magnética Nuclear. Rev Port Cardiol 2004;23:1643-46.
40. Weidemann F, Breunig F, Beer M, et al. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J 2005;26:1221-7.